Involvement and relationship of bacterial lipopolysaccharides and cyclooxygenases levels in Alzheimer’s Disease and Mild Cognitive Impairment patients

G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences

Faul, F., Erdfelder, E., Lang, A.-G., & Buchner, A. (2007) · Behavior Research Methods · doi:10.3758/bf03193146 · Cited by 65,971 · see citing works

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

Neuroinflammation in Alzheimer's disease

Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226 · see citing works

Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases

Franceschi, C., & Campisi, J. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu057 · Cited by 3,891 · see citing works

The neuropathological diagnosis of Alzheimer's disease

DeTure, M. A., & Dickson, D. W. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0333-5 · Cited by 3,329 · see citing works

LPS/TLR4 signal transduction pathway

Lu, Y.-C., Yeh, W.-C., & Ohashi, P. S. (2008) · Cytokine · doi:10.1016/j.cyto.2008.01.006 · Cited by 3,301 · see citing works

Alzheimer's disease

Lane, C. A., Hardy, J., & Schott, J. M. (2018) · European Journal of Neurology · doi:10.1111/ene.13439 · Cited by 2,616 · see citing works

<i>Porphyromonas gingivalis</i> in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors

Dominy, S. S., Lynch, C., Ermini, F., Benedyk, M., Marczyk, A., Konradi, A., Nguyen, M., Haditsch, U., Raha, D., Griffin, C., et al. (2019) · Science Advances · doi:10.1126/sciadv.aau3333 · Cited by 1,966 · see citing works

Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice

Zhao, J., Bi, W., Xiao, S., Lan, X., Cheng, X., Zhang, J., Lu, D., Wei, W., Wang, Y., Li, H., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-42286-8 · Cited by 905 · see citing works

Cyclooxygenase-2 (COX-2) in Inflammatory and Degenerative Brain Diseases

Minghetti, L. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.9.901 · Cited by 780 · see citing works

Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation

Lee, J. W., Lee, Y. K., Yuk, D. Y., Choi, D. Y., Ban, S. B., Oh, K. W., & Hong, J. T. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-37 · Cited by 772 · see citing works

The blood-brain barrier in Alzheimer’s disease

Zenaro, E., Piacentino, G., & Constantin, G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.007 · Cited by 767 · see citing works

Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock

van Amersfoort, E. S., van Berkel, T. J. C., & Kuiper, J. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.379-414.2003 · Cited by 750 · see citing works

Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease

Kitazawa, M., Oddo, S., Yamasaki, T. R., Green, K. N., & LaFerla, F. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2868-05.2005 · Cited by 697 · see citing works

Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer’s disease

Minter, M. R., Zhang, C., Leone, V., Ringus, D. L., Zhang, X., Oyler-Castrillo, P., Musch, M. W., Liao, F., Ward, J. F., Holtzman, D. M., et al. (2016) · Scientific Reports · doi:10.1038/srep30028 · Cited by 655 · see citing works

Lipopolysaccharide-induced blood-brain barrier disruption: Roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit

Banks, W. A., Gray, A. M., Erickson, M. A., Salameh, T. S., Damodarasamy, M., Sheibani, N., Meabon, J. S., Wing, E. E., Morofuji, Y., Cook, D. G., et al. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0434-1 · Cited by 636 · see citing works

Why there are two cyclooxygenase isozymes

Smith, W. L., & Langenbach, R. J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13271 · Cited by 612 · see citing works

What is an ROC curve?

Hoo, Z. H., Candlish, J., & Teare, M. D. (2017) · Emergency Medicine Journal · doi:10.1136/emermed-2017-206735 · Cited by 558 · see citing works

Lipopolysaccharide-induced neuroinflammation as a bridge to understand neurodegeneration

Batista, C. R. A., Gomes, G. F., Candelario-Jalil, E., Fiebich, B. L., & de Oliveira, A. C. P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092293 · Cited by 529 · see citing works

Gram-negative bacterial molecules associate with Alzheimer disease pathology

Zhan, X., Stamova, B., Jin, L.-W., DeCarli, C., Phinney, B., & Sharp, F. R. (2016) · Neurology · doi:10.1212/wnl.0000000000003391 · Cited by 521 · see citing works

Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain

Balin, B. J., Gérard, H. C., Arking, E. J., Appelt, D. M., Branigan, P. J., Abrams, J. T., Whittum-Hudson, J. A., & Hudson, A. P. (1998) · Medical Microbiology and Immunology · doi:10.1007/s004300050071 · Cited by 506 · see citing works

Neuroinflammation in the pathogenesis of Alzheimer’s disease. A rational framework for the search of novel therapeutic approaches

Morales, I., Guzmán-Martínez, L., Cerda-Troncoso, C., Farías, G. A., & Maccioni, R. B. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00112 · Cited by 490 · see citing works

Distinct functions of COX-1 and COX-2

Morita, I. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00029-1 · Cited by 464 · see citing works

Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: Their role and involvement in neurological disorders

Phillis, J. W., Horrocks, L. A., & Farooqui, A. A. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.02.002 · Cited by 456 · see citing works

The antimicrobial protection hypothesis of Alzheimer’s disease

Moir, R. D., Lathe, R., & Tanzi, R. E. (2018) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2018.06.3040 · Cited by 456 · see citing works

A benzene-degrading nitrate-reducing microbial consortium displays aerobic and anaerobic benzene degradation pathways

Atashgahi, S., Hornung, B., van der Waals, M. J., da Rocha, U. N., Hugenholtz, F., Nijsse, B., Douwe Molenaar, B., van Spanning, R. J. M., Stams, A. J. M., Gerritse, J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22617-x · Cited by 449 · see citing works

Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement

Albillos, A., de la Hera, A., González, M., Moya, J. L., Calleja, J. L., Monserrat, J., Ruíz-del-Árbol, L., & Álvarez‐Mon, M. (2003) · Hepatology · doi:10.1053/jhep.2003.50038 · Cited by 445 · see citing works

Bacterial Endotoxin Activity in Human Serum Is Associated With Dyslipidemia, Insulin Resistance, Obesity, and Chronic Inflammation

Lassenius, M., Pietiläinen, K., Kaartinen, K., Pussinen, P., Syrjänen, J., Forsblom, C., Pörsti, I., Rissanen, A., Kaprio, J., Mustonen, J., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2197 · Cited by 404 · see citing works

A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment

on behalf of the Rofecoxib Protocol 078 study group, Thal, L. J., Ferris, S. H., Kirby, L., Block, G. A., Lines, C. R., Yuen, E., Assaid, C., Nessly, M. L., Norman, B. A., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300690 · Cited by 402 · see citing works

The Infectious Etiology of Alzheimer’s Disease

Sochocka, M., Zwolińska, K., & Leszek, J. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170313122937 · Cited by 399 · see citing works

Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid β peptide in APPswe transgenic mice

Sheng, J. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00069-x · Cited by 388 · see citing works

Secretory Products of the Human GI Tract Microbiome and Their Potential Impact on Alzheimer's Disease (AD): Detection of Lipopolysaccharide (LPS) in AD Hippocampus

Zhao, Y., Jaber, V., & Lukiw, W. J. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00318 · Cited by 379 · see citing works

Rofecoxib

Reines, S. A., Block, G. A., Morris, J. C., Liu, G., Nessly, M. L., Lines, C. R., Norman, B., & Baranak, C. C. (2004) · Neurology · doi:10.1212/wnl.62.1.66 · Cited by 378 · see citing works

LPS-induced Murine Neuroinflammation Model: Main Features and Suitability for Pre-clinical Assessment of Nutraceuticals

Catorce, M. N., & Gevorkian, G. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666151204122017 · Cited by 361 · see citing works

Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria

Judith Miklossy, A. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-90 · Cited by 356 · see citing works

Lipopolysaccharide Associates with Amyloid Plaques, Neurons and Oligodendrocytes in Alzheimer’s Disease Brain: A Review

Zhan, X., Stamova, B. S., & Sharp, F. R. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00042 · Cited by 354 · see citing works

Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes

Jayashree, B., Bibin, Y. S., Prabhu, D., Shanthirani, C. S., Gokulakrishnan, K., Lakshmi, B. S., Mohan, V., & Balasubramanyam, M. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1911-4 · Cited by 353 · see citing works

Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS)

Zhang, R., Miller, R. G., Gascon, R., Champion, S., Katz, J., Lancero, M., Narvaez, A., Honrada, R., Ruvalcaba, D., & McGrath, M. S. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.09.017 · Cited by 319 · see citing works

Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis

Michelena, J., Altamirano, J., Abraldeṣ, J. G., Affò, S., Morales‐Ibanez, O., Sancho‐Bru, P., Domínguez, M., García‐Pagán, J. C., Fernández, J., Arroyo, V., et al. (2015) · Hepatology · doi:10.1002/hep.27779 · Cited by 293 · see citing works

Astrocytes: Implications for Neuroinflammatory Pathogenesis of Alzheimers Disease

Li, C., Zhao, R., Gao, K., Wei, Z. Z., Yin, M. Y., Lau, L. T., Chui, D., & Yu, A. C. (2011) · Current Alzheimer Research · doi:10.2174/156720511794604543 · Cited by 291 · see citing works

Induction of COX‐2 by LPS in macrophages is regulated by Tpl2‐dependent CREB activation signals

Eliopoulos, A. G., Dumitru, C. D., Wang, C., Cho, J., & Tsichlis, P. N. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf478 · Cited by 284 · see citing works

Role of inducible cyclooxygenase (COX-2) in inflammation.

Seibert, K., & Masferrer, J. L. (1994) · PubMed · Cited by 273 · see citing works

Understanding the Role of Systemic Inflammation in Alzheimer’s Disease

Walker, K. A., Ficek, B. N., & Westbrook, R. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00333 · Cited by 259 · see citing works

Targeting cyclooxygenases-1 and -2 in neuroinflammation: Therapeutic implications

Aïd, S., & Bosetti, F. (2010) · Biochimie · doi:10.1016/j.biochi.2010.09.009 · Cited by 253 · see citing works

Induction by lipopolysaccharide of cyclooxygenase-2 mRNA in rat brain; its possible role in the febrile response

Cao, C., Matsumura, K., Yamagata, K., & Watanabe, Y. (1995) · Brain Research · doi:10.1016/0006-8993(95)00839-i · Cited by 252 · see citing works

Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brain

Hoozemans, J. J. M., Rozemüller, A. J. M., Janssen, I., Groot, C. J. A. D., Veerhuis, R., & Eikelenboom, P. (2001) · Acta Neuropathologica · doi:10.1007/s004010000251 · Cited by 246 · see citing works

Measuring cytokine levels in blood

Thavasu, P. W., Longhurst, S., Joel, S. P., Slevin, M. L., & Balkwill, F. R. (1992) · Journal of Immunological Methods · doi:10.1016/0022-1759(92)90313-i · Cited by 241 · see citing works

Differential Induction of the Toll-Like Receptor 4-MyD88-Dependent and -Independent Signaling Pathways by Endotoxins

Zughaier, S. M., Zimmer, S. M., Datta, A., Carlson, R. W., & Stephens, D. S. (2005) · Infection and Immunity · doi:10.1128/iai.73.5.2940-2950.2005 · Cited by 240 · see citing works

Expression and Regulation of Cyclooxygenase‐2 in Rat Microglia

Bauer, M. K. A., Lieb, K., Schulze‐Osthoff, K., Berger, T., Gebicke‐Haerter, P. J., Bauer, J., & Fiebich, B. L. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00726.x · Cited by 235 · see citing works

Effect of LPS on the permeability of the blood–brain barrier to insulin

Xaio, H., Banks, W. A., Niehoff, M. L., & Morley, J. E. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03247-9 · Cited by 231 · see citing works

Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease

Pastor, Ó., López–Sanromán, A., Albéniz, E., Martínez, A. D. L. H., Sevillano, E. R., & Albillos, A. (2006) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20019 · Cited by 229 · see citing works

Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy

Takeda, S., Sato, N., & Morishita, R. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00171 · Cited by 226 · see citing works

Alzheimer’s disease as an inflammatory disease

Bolós, M., Perea, J. R., & Avila, J. (2017) · BioMolecular Concepts · doi:10.1515/bmc-2016-0029 · Cited by 216 · see citing works

Inflammation Induced by Infection Potentiates Tau Pathological Features in Transgenic Mice

Sy, M., Kitazawa, M., Medeiros, R., Whitman, L., Cheng, D., Lane, T. E., & LaFerla, F. M. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.02.012 · Cited by 210 · see citing works

Induction of COX-2 Enzyme and Down-regulation of COX-1 Expression by Lipopolysaccharide (LPS) Control Prostaglandin E2 Production in Astrocytes

Font-Nieves, M., Sans-Fons, M. G., Gorina, R., Bonfill‐Teixidor, E., Salas-Perdomo, A., Márquez‐Kisinousky, L., Santalucı́a, T., & Planas, A. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.327874 · Cited by 204 · see citing works

Historic evidence to support a causal relationship between spirochetal infections and Alzheimer’s disease

Miklossy, J. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00046 · Cited by 203 · see citing works

Gut Microbiota-Dependent Trimethylamine-N-oxide and Serum Biomarkers in Patients with T2DM and Advanced CKD

Al-Obaide, M. A. I., Singh, R., Datta, P., Rewers-Felkins, K., Salguero, M. V., Al‐Obaidi, I., Kottapalli, K. R., & Vasylyeva, T. L. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6090086 · Cited by 200 · see citing works

Emerging roles of pathogens in Alzheimer disease

Miklossy, J. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411002006 · Cited by 199 · see citing works

Neuronal Cyclooxygenase 2 Expression in the Hippocampal Formation as a Function of the Clinical Progression of Alzheimer Disease

Ho, L., Purohit, D. P., Haroutunian, V. H., Luterman, J. D., Willis, F., Näslund, J., Buxbaum, J. D., Mohs, R. C., Aisen, P. S. S., & Pasinetti, G. M. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.487 · Cited by 196 · see citing works

Alzheimer's Associated β-Amyloid Protein Inhibits Influenza A Virus and Modulates Viral Interactions with Phagocytes

White, M. R., Kandel, R., Tripathi, S., Condon, D., Qi, L., Taubenberger, J., & Hartshorn, K. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101364 · Cited by 193 · see citing works

Neurobiology of Alzheimer’s Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive Dimensions

Raskin, J., Cummings, J. L., Hardy, J., Schuh, K. J., & Dean, R. A. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150701103107 · Cited by 190 · see citing works

Cyclooxygenase-1 in Human Alzheimer and Control Brain: Quantitative Analysis of Expression by Microglia and CA3 Hippocampal Neurons

Yermakova, A., Rollins, J., Callahan, L. M., Rogers, J., & O’Banion, M. K. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199911000-00003 · Cited by 187 · see citing works

Bacterial Infection and Alzheimer's Disease: A Meta-Analysis

Maheshwari, P., & Eslick, G. D. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140621 · Cited by 183 · see citing works

COX-3 and the mechanism of action of paracetamol/acetaminophen

Botting, R. M., & Ayoub, S. S. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2004.10.005 · Cited by 180 · see citing works

Can a Bacterial Endotoxin be a Key Factor in the Kinetics of Amyloid Fibril Formation?

Asti, A., & Gioglio, L. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-131394 · Cited by 180 · see citing works

The Possibility of an Infectious Etiology of Alzheimer Disease

Ashraf, G. M., Tarasov, V. V., Makhmutovа, A., Chubarev, V. N., Avila-Rodriguez, M., Bachurin, S. O., & Aliev, G. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1388-y · Cited by 175 · see citing works

Cyclooxygenase 2 mRNA expression in rat brain after peripheral injection of lipopolysaccharide

Quan, N., Whiteside, M. B., & Herkenham, M. A. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00402-8 · Cited by 172 · see citing works

Microbiome-Derived Lipopolysaccharide Enriched in the Perinuclear Region of Alzheimer’s Disease Brain

Zhao, Y., Cong, L., Jaber, V. R., & Lukiw, W. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01064 · Cited by 170 · see citing works

Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology

Hoozemans, J. J. M., Veerhuis, R., Rozemüller, A. J. M., & Eikelenboom, P. (2005) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.11.001 · Cited by 168 · see citing works

Lipopolysaccharide-Induced Memory Impairment in Rats: a Model of Alzheimer’s Disease

ZAKARIA, R., WAN YAACOB, W. M. H., OTHMAN, Z., LONG, I., AHMAD, A. H., & AL-RAHBI, B. (2017) · Physiological Research · doi:10.33549/physiolres.933480 · Cited by 167 · see citing works

Physiologic and pathophysiologic roles of lipid mediators in the kidney

Hao, C., & Breyer, M. D. (2007) · Kidney International · doi:10.1038/sj.ki.5002192 · Cited by 167 · see citing works

Genetic deletion or pharmacological inhibition of cyclooxygenase‐1 attenuate lipopolysaccharide‐ induced inflammatory response and brain injury

Choi, S., Langenbach, R. I., & Bosetti, F. (2007) · The FASEB Journal · doi:10.1096/fj.07-9411com · Cited by 158 · see citing works

Low‐grade endotoxemia and platelet activation in cirrhosis

Raparelli, V., Basili, S., Carnevale, R., Napoleone, L., Del Ben, M., Nocella, C., Bartimoccia, S., Lucidi, C., Talerico, G., Riggio, O., et al. (2017) · Hepatology · doi:10.1002/hep.28853 · Cited by 142 · see citing works

Oxidative Stress Mediated Mitochondrial and Vascular Lesions as Markers in the Pathogenesis of Alzheimer Disease

Aliev, G., Priyadarshini, M., Reddy, V., Grieg, N. H., Kaminsky, Y., Cacabelos, R., Ashraf, G., Jabir, N. R., Kamal, M. A., Nikolenko, V. N., et al. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666131227161303 · Cited by 138 · see citing works

Role of Toll Like Receptor 4 in Alzheimer’s Disease

Calvo-Rodriguez, M., García-Rodríguez, C., Villalobos, C., & Núñez, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01588 · Cited by 136 · see citing works

TRPV4 activation triggers protective responses to bacterial lipopolysaccharides in airway epithelial cells

Alpizar, Y. A., Boonen, B., Sánchez, A., Jung, C., López‐Requena, A., Naert, R., Steelant, B., Luyts, K., Plata, C., Vooght, V. D., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01201-3 · Cited by 126 · see citing works

6-Gingerol attenuates LPS-induced neuroinflammation and cognitive impairment partially via suppressing astrocyte overactivation

Zhang, F., Zhang, J.-G., Yang, W., Xu, P., Xiao, Y., & Zhang, H. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.136 · Cited by 123 · see citing works

Brain-reactive autoantibodies are nearly ubiquitous in human sera and may be linked to pathology in the context of blood–brain barrier breakdown

Levin, E. C., Acharya, N. K., Han, M. C., Zavareh, S., Sedeyn, J. C., Venkataraman, V., & Nagele, R. G. (2010) · Brain Research · doi:10.1016/j.brainres.2010.05.038 · Cited by 113 · see citing works

Increased Cerebrospinal Fluid Helicobacter Pylori Antibody in Alzheimer’s Disease

Kountouras, J., Boziki, M. K., Gavalas, E., Zavos, C., Deretzi, G., Grigoriadis, N., Tsolaki, M., Chatzopoulos, D., Katsinelos, P., Tzilves, D., et al. (2009) · International Journal of Neuroscience · doi:10.1080/00207450902782083 · Cited by 113 · see citing works

Serum Lipopolysaccharide Activity Is Associated With the Progression of Kidney Disease in Finnish Patients With Type 1 Diabetes

Nymark, M., Pussinen, P. J., Tuomainen, A. M., Forsblom, C. M., Groop, P., Lehto, M. J., & on behalf of the FinnDiane Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0467 · Cited by 111 · see citing works

Cyclooxygenase (COX)-2 and COX-1 Potentiate β-Amyloid Peptide Generation through Mechanisms That Involve γ-Secretase Activity

Qin, W., Ho, L., Pompl, P. N., Peng, Y., Zhao, Z., Xiang, Z., Robakis, N. K. R. K., Shioi, J., Suh, J., & Pasinetti, G. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307699200 · Cited by 110 · see citing works

Periodontal Health Condition in Patients With Alzheimer’s Disease

Martande, S., Pradeep, A. R., Singh, S. P., Kumari, M., Suke, D. K., Raju, A. P., Naik, S. B., Singh, P., Guruprasad, C. N., & Chatterji, A. (2014) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317514549650 · Cited by 110 · see citing works

Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer’s disease model mice

Woodling, N. S., Colas, D., Wang, Q., Minhas, P. S., Panchal, M., Liang, X., Mhatre, S. D., Brown, H. D., Ko, N., Zagol-Ikapitte, I. A., et al. (2016) · Brain · doi:10.1093/brain/aww117 · Cited by 108 · see citing works

Role of COX-2 in Inflammatory and Degenerative Brain Diseases

Minghetti, L. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/1-4020-5688-5_5 · Cited by 104 · see citing works

Technological advances and changing indications for lumbar puncture in neurological disorders

Costerus, J. M., Brouwer, M. C., & van de Beek, D. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30033-4 · Cited by 103 · see citing works

Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia

Jordan, F., Quinn, T. J., McGuinness, B., Passmore, P., Kelly, J. P., Smith, C. T., Murphy, K., & Devane, D. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011459.pub2 · Cited by 101 · see citing works

Detectable serum flagellin and lipopolysaccharide and upregulated anti-flagellin and lipopolysaccharide immunoglobulins in human short bowel syndrome

Ziegler, T. R., Luo, M., Estívariz, C. F., Moore, D. A., Sitaraman, S. V., Li, H., Bazargan, N., Klapproth, J. A., Tian, J. J., Galloway, J. R., et al. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00650.2007 · Cited by 96 · see citing works

Prenatal exposure to lipopolysaccharide results in cognitive deficits in age-increasing offspring rats

Hao, L.-Y., Hao, X. Q., Li, S. H., & Li, X. H. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.01.006 · Cited by 93 · see citing works

Loss of tau rescues inflammation-mediated neurodegeneration

Maphis, N., Xu, G., Kokiko-Cochran, O. N., Cardona, A. E., Ransohoff, R. M., Lamb, B. T., & Bhaskar, K. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00196 · Cited by 91 · see citing works

Differential effects of lipopolysaccharide on mouse sensory TRP channels

Boonen, B., Alpizar, Y. A., Sánchez, A., López‐Requena, A., Voets, T., & Talavera, K. (2018) · Cell Calcium · doi:10.1016/j.ceca.2018.04.004 · Cited by 91 · see citing works

Cerebrovascular Cyclooxygenase-1 Expression, Regulation, and Role in Hypothalamic-Pituitary-Adrenal Axis Activation by Inflammatory Stimuli

García‐Bueno, B., Serrats, J., & Sawchenko, P. E. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2373-09.2009 · Cited by 90 · see citing works

Synaptic and Vascular Associations of Neurons Containing Cyclooxygenase-2 and Nitric Oxide Synthase in Rat Somatosensory Cortex

Wang, H., Hitron, I. M., Iadecola, C., & Pickel, V. M. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhi008 · Cited by 88 · see citing works

Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer's mouse model: Implication of TLR4 signaling in disease progression

Go, M., Kou, J., Lim, J.-E., Yang, J., & Fukuchi, K.-I. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.073 · Cited by 87 · see citing works

Cyclooxygenase-1 null mice show reduced neuroinflammation in response to β-amyloid

Choi, S., & Bosetti, F. (2009) · Aging · doi:10.18632/aging.100021 · Cited by 84 · see citing works

Identification of brain-enriched proteins in the cerebrospinal fluid proteome by LC-MS/MS profiling and mining of the Human Protein Atlas

Begcevic, I., Brinc, D., Drabovich, A. P., Batruch, I., & Diamandis, E. P. (2016) · Clinical Proteomics · doi:10.1186/s12014-016-9111-3 · Cited by 84 · see citing works

Correlative Light-Electron Microscopy detects lipopolysaccharide and its association with fibrin fibres in Parkinson’s Disease, Alzheimer’s Disease and Type 2 Diabetes Mellitus

de Waal, G. M., Engelbrecht, L., Davis, T., de Villiers, W. J. S., Kell, D. B., & Pretorius, E. (2018) · Scientific Reports · doi:10.1038/s41598-018-35009-y · Cited by 79 · see citing works

The Predicted Key Molecules, Functions, and Pathways That Bridge Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)

Tao, Y., Han, Y., Yu, L., Wang, Q., Leng, S. X., & Zhang, H. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00233 · Cited by 78 · see citing works

Lipopolysaccharide endotoxemia induces amyloid-β and p-tau formation in the rat brain.

Wang, L., Wu, Q., Kirk, R. A., Horn, K. P., Salem, A. E., Hoffman, J. M., Yap, J. T., Sonnen, J. A., Towner, R. A., Bozza, F. A., et al. (2018) · Europe PMC (PubMed Central) · Cited by 73 · see citing works

COX-1 and COX-2 contribute differentially to the LPS-induced release of PGE2 and TxA2 in liver macrophages

Bezugla, Y., Kolada, A., Kamionka, S., Bernard, B., Scheibe, R., & Dieter, P. (2005) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2005.11.001 · Cited by 62 · see citing works

Amelioration of oxidative stress and neuroinflammation in lipopolysaccharide-induced memory impairment using Rosmarinic acid in mice

Thingore, C., Kshirsagar, V. V., & Juvekar, A. R. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00629-9 · Cited by 60 · see citing works

Suppression of LPS-induced tau hyperphosphorylation by serum amyloid A

Liu, J., Wang, D., Li, S.-Q., Yu, Y., & Ye, R. D. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0493-y · Cited by 58 · see citing works

The last neuronal division: a unifying hypothesis for the pathogenesis of Alzheimer's disease

Nagy, Z. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00485.x · Cited by 56 · see citing works

Detection of Cyclooxygenase-1 in Activated Microglia During Amyloid Plaque Progression: PET Studies in Alzheimer’s Disease Model Mice

Shukuri, M., Mawatari, A., Ohno, M., Suzuki, M., Doi, H., Watanabe, Y., & Onoe, H. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.166116 · Cited by 55 · see citing works

Taraxerol inhibits LPS-induced inflammatory responses through suppression of TAK1 and Akt activation

Yao, X., Li, G., Bai, Q., Xu, H., & Lü, C. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2012.12.032 · Cited by 54 · see citing works

Immuno-localization of COX-1 and COX-2 in the rat molar periodontal tissue after topical application of lipopolysaccharide

Miyauchi, M., Hiraoka, M., Oka, H., Sato, S., Kudo, Y., Ogawa, I., Noguchi, K., Ishikawa, I., & Takata, T. (2004) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2004.04.004 · Cited by 51 · see citing works

Continuous intracerebroventricular injection of Porphyromonas gingivalis lipopolysaccharide induces systemic organ dysfunction in a mouse model of Alzheimer's disease

Hayashi, K., Hasegawa, Y., Takemoto, Y., Cao, C., Takeya, H., Komohara, Y., Mukasa, A., & Kim‐Mitsuyama, S. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.02.007 · Cited by 50 · see citing works

Evaluation of CSF-Chlamydia pneumoniae, CSF-tau, and CSF-Abeta42 in Alzheimer’s disease and vascular dementia

Paradowski, B., Jaremko, M., Dobosz, T., Leszek, J., & Noga, L. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0298-5 · Cited by 48 · see citing works

Lipopolysaccharide-Induced Exosomal miR-146a Is Involved in Altered Expression of Alzheimer’s Risk Genes Via Suppression of TLR4 Signaling

Yang, J., Malone, F., Go, M., Kou, J., Lim, J.-E., Caughey, R. C., & Fukuchi, K.-I. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01750-1 · Cited by 46 · see citing works

Alzheimer CSF biomarkers in routine clinical setting

Tabaraud, F., Leman, J. P., Milor, A.-M., Roussie, J. M., Barrière, G., Tartary, M., Boutros-Toni, F., & Rigaud, M. (2011) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2011.01592.x · Cited by 44 · see citing works

Link Between Chronic Bacterial Inflammation and Alzheimer Disease

Bibi, F., Yasir, M., Sohrab, S. S., Azhar, E. I., Al-Qahtani, M., Abuzenadah, A. M., Kamal, M. A., & Naseer, M. I. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666140917115741 · Cited by 43 · see citing works

Inhibition of apoptosis in neuronal cells infected with Chlamydophila (Chlamydia) pneumoniae

Appelt, D. M., Roupas, M. R., Way, D. S., Bell, M. G., Albert, E. V., Hammond, C. J., & Balin, B. J. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-13 · Cited by 39 · see citing works

Cyclooxygenase (COX)-1 Activity Precedes the COX-2 Induction in Aβ-Induced Neuroinflammation

Dargahi, L., Nasiraei-Moghadam, S., Abdi, A., Khalaj, L., Moradi, F., & Ahmadiani, A. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9401-6 · Cited by 33 · see citing works

Rhamnolipids, Microbial Virulence Factors, in Alzheimer’s Disease

Andreadou, E. G., Pantazaki, Α. A., Daniilidou, M., & Tsolaki, M. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161020 · Cited by 30 · see citing works

Imatinib methanesulfonate reduces hyperphosphorylation of tau following repeated peripheral exposure to lipopolysaccharide

Gardner, L. E., White, J. D., Eimerbrink, M. J., Boehm, G. W., & Chumley, M. J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.06.007 · Cited by 29 · see citing works

Frontiers in Anti-Infective Drug Discovery

(2017) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/97816810829121170501 · Cited by 24 · see citing works

Alternative Anti-Infective/Anti-Inflammatory Therapeutic Options for Fighting Alzheimer’s Disease

(2017) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781681084794117060003 · Cited by 7 · see citing works

Implications of Gut Microbiota in Neurodegenerative Diseases

Zhang, H., Chen, Y., Wang, Z., Xie, G., Liu, M., Yuan, B., Chai, H., Wang, W., & Cheng, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.785644 · Cited by 157 · see citing works

The endotoxin hypothesis of Alzheimer’s disease

Brown, G. C., & Heneka, M. T. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00722-y · Cited by 140 · see citing works

Fecal Microbiota Transplantation Improves Cognitive Function of a Mouse Model of Alzheimer's Disease

Jiang, X., Zheng, Y., Sun, H., Dang, Y., Yin, M., Xiao, M., & Wu, T. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70259 · Cited by 35 · see citing works

Microbial lipopolysaccharide‐induced inflammation contributes to cognitive impairment and white matter lesion progression in diet‐induced obese mice with chronic cerebral hypoperfusion

Inaba, T., Yamashiro, K., Kurita, N., Ueno, Y., Miyamoto, N., Hira, K., Nakajima, S., Kijima, C., Nakaguro, R., Urabe, T., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14301 · Cited by 32 · see citing works

NLRP3 inflammasome of microglia promotes A1 astrocyte transformation, neo-neuron decline and cognition impairment in endotoxemia

Xiao, T., Ji, H., Shangguan, X., Qu, S., Cui, Y., & Xu, J. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.02.092 · Cited by 26 · see citing works

Metagenomic association analysis of cognitive impairment in community-dwelling older adults

Li, J., Zhu, S., Wang, Y., Fan, M., Dai, J., Zhu, C., Xu, K., Cui, M., Suo, C., Li, J., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106081 · Cited by 26 · see citing works

TET2-mutant myeloid cells mitigate Alzheimer’s disease progression via CNS infiltration and enhanced phagocytosis in mice

Matatall, K. A., Wathan, T. K., Nguyen, M., Chen, H., McDonald, A., Qi, G., Belk, J. A., Florez, M. A., Le, D. T., Olarinde, T., et al. (2025) · Cell Stem Cell · doi:10.1016/j.stem.2025.06.006 · Cited by 23 · see citing works

Relationship Between Plasma Lipopolysaccharides, Gut Microbiota, and Dementia: A Cross-Sectional Study

Saji, N., Saito, Y., Yamashita, T., Murotani, K., Tsuduki, T., Hisada, T., Sugimoto, T., Niida, S., Toba, K., & Sakurai, T. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215653 · Cited by 20 · see citing works

Microbial Metabolomes in Alzheimer’s Disease: From Pathogenesis to Therapeutic Potential

Borrego-Ruiz, A., & Borrego, J. J. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47090724 · Cited by 20 · see citing works

The past, present, and future of research on neuroinflammation-induced mild cognitive impairment: A bibliometric analysis

Cai, M., Zhang, Y., Chen, S. X., Wu, Z., & Zhu, L. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.968444 · Cited by 18 · see citing works

From Gut to Brain: Uncovering Potential Serum Biomarkers Connecting Inflammatory Bowel Diseases to Neurodegenerative Diseases

Sârb, O. F., Sârb, A.-D., Iacobescu, M., Vlad, I. M., Milaciu, M. V., Ciumărnean, L., Văcăraș, V., & Tanțău, A. I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115676 · Cited by 19 · see citing works

The relationship between increased levels of microbiota-derived lipopolysaccharide in obesity and the pathophysiology of neurodegenerative diseases

Mehboodi, M., Namdari, M. P., Abdollahi, Z., Mobarezi, Z., Kiani, M., Chamani, F., Khanbabaie, H., Rabiei, S., Maleki, M. H., Sanati, H., et al. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107905 · Cited by 14 · see citing works

Gut microbiome‐derived metabolites in Alzheimer's disease: Regulation of immunity and potential for therapeutics

Chandra, S., & Vassar, R. J. (2024) · Immunological Reviews · doi:10.1111/imr.13412 · Cited by 14 · see citing works

The Microbiome–Neurodegeneration Interface: Mechanisms, Evidence, and Future Directions

Böckels, L., Alexa, D., Antal, D. C., Gațcan, C., Alecu, C., Kacani, K., Cretu, R. A., Piseru, E.-A., Bîlcu, R. V., & Cuciureanu, D. I. (2026) · Cells · doi:10.3390/cells15020135 · Cited by 12 · see citing works

Unraveling the Protective Role of Oleocanthal and Its Oxidation Product, Oleocanthalic Acid, against Neuroinflammation

Barbalace, M. C., Freschi, M., Rinaldi, I., Zallocco, L., Malaguti, M., Manera, C., Ortore, G., Zuccarini, M., Ronci, M., Cuffaro, D., et al. (2024) · Antioxidants · doi:10.3390/antiox13091074 · Cited by 12 · see citing works

Microbiota and Alzheimer’s disease: mechanistic insights from a multi-organ perspective

Liao, J., Mou, H., Luo, S., Shen, L., & Jiao, B. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00541-9 · Cited by 10 · see citing works

The Common Alzheimer's Disease Research Ontology (CADRO) for biomarker categorization

Osse, A. M. L., Kinney, J., & Cummings, J. L. (2025) · Alzheimer's & Dementia · doi:10.1002/trc2.70050 · Cited by 11 · see citing works

Endotoxins and Metabolic Endotoxemia in Obesity and Associated Noncommunicable Diseases: A Focus on Sex Differences

Cornò, M. D., Aureli, A., Varano, B., & Conti, L. (2026) · Biomolecules · doi:10.3390/biom16020226 · Cited by 7 · see citing works

Gut Microbiota Dysbiosis and Neuroinflammation in Alzheimer’s Disease: a Systematic Review of Mechanistic Insights

Katsigianni, S., & Koutsouraki, E. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05914-9 · Cited by 7 · see citing works

Evaluation of the Anti-Amyloid and Anti-Inflammatory Properties of a Novel Vanadium(IV)–Curcumin Complex in Lipopolysaccharides-Stimulated Primary Rat Neuron-Microglia Mixed Cultures

Katsipis, G., Lavrentiadou, S. N., Geromichalos, G. D., Tsantarliotou, M. P., Halevas, E. G., Litsardakis, G., & Pantazaki, Α. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010282 · Cited by 4 · see citing works

Localization and Pathological Implications of Lipopolysaccharide in the Brains of 5XFAD Mice

Shin, S. J., Park, Y. H., Nam, Y., Chung, H., Kim, S.-J., & Moon, M. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05107-w · Cited by 4 · see citing works

Microbial Trojan Horses: Virulence Factors as Key Players in Neurodegenerative Diseases

Grahl, M. V. C., Hohl, K. S., Smaniotto, T. Â., & Carlini, C. R. (2025) · Molecules · doi:10.3390/molecules30030687 · Cited by 4 · see citing works

Investigation for the involvement of microbial FliC and DING proteins in Alzheimer's Disease and Mild Cognitive Impairment and correlation with neurodegeneration and inflammation markers

Andreadou, E. G., Katsipis, G., Tsolaki, M., & Pantazaki, Α. A. (2023) · Brain Disorders · doi:10.1016/j.dscb.2023.100091 · Cited by 3 · see citing works

Association between cognitive functioning and microbiota-gut-brain axis mediators in a memory clinic population

Solorzano, C. S., Festari, C., Mirabelli, P., Mombelli, E., Coppola, L., Luongo, D., Naviglio, D., Soricelli, A., Quattrini, G., Salvatore, M., et al. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1550333 · Cited by 3 · see citing works

Influence of postbiotics on the microbiota-gut-brain axis in cognitive impairment and dementia

Kang, T.-B., Lee, J. Y., & Cheon, S. Y. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107279 · Cited by 2 · see citing works

Microbiome functional gene pathways predict cognitive performance in older adults with Alzheimer’s diseasePreprint

Zeamer, A. L., Lai, Y., Sanborn, V. E., Loew, E. B., Tracy, M., Jo, C., Ward, D. V., Bhattarai, S. K., Drake, J., McCormick, B. A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.06.641911 · Cited by 2 · see citing works

Causal effect of serum lipopolysaccharide activity levels and inflammatory proteins on Alzheimer's disease: A Mendelian randomization study combined with meta-analysis in a large-scale cohort

Niu, L., Li, Y., Wu, H., Zhao, L., Zhang, J., Lü, F., Zhao, G., Jia, F., Zhu, J., & Liu, M. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251385589 · Cited by 1 · see citing works

Therapeutic potential of phytochemicals and role of gut microbiota in neurodegenerative diseases

Gupta, S. K., & Sharma, R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-36372-6.00014-8 · Cited by 1 · see citing works

In vitro and in silico evaluation of the anti-amyloid and anti-inflammatory properties of curcumin and a V (IV) – curcumin complex in LPS-stimulated primary rat neurons-microglia mixed culturesPreprint

Katsipis, G., Lavrentiadou, S. N., Geromichalos, G. D., Tsantarliotou, M. P., Halevas, E. G., Litsardakis, G., & Pantazaki, Α. A. (2023) · Research Square · doi:10.21203/rs.3.rs-3148454/v1

The Link Between Periodontal Disease and Alzheimer's Disease: a narrative review

Gęborys, K., Burzykowska, K., Trela, K., Więcko, L., Tuteja, A., Olczyk, L., & Podleśna, D. (2025) · Quality in Sport · doi:10.12775/qs.2025.41.60400

Metabolic endotoxemia in metabolic and neurodegenerative diseases

Li, C., Jiang, W., & Lu, M. (2026) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2026130

P3‐174: QUANTITATION OF THE BACTERIAL PRODUCT LIPOPOLYSACCHARIDE (LPS) IN POSTMORTEM SERUM AND BRAIN TISSUE FROM AD, MCI, AND CONTROL PATIENTS

Jentarra, G. M., Chu, P., Elliott, N. M., Jones, T. B., Kaufman, J. A., Vallejo, J., Jones, D. C., Gonzalez, F., Tullot, T., & Potter, P. E. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.06.3203

Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease

Ahmad, S., Orellana, A., Köhler, I., Frölich, L., de Rojas, I., Gil, S., Boada, M., Hernández, I., Hausner, L., Bakker, M. H. M., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00680-9 · Cited by 25 · see citing works

PT574. The increased serum lipopolysaccharides was associated with the TNFa and formation of ß amyloid protein in Alzheimer’s disease patients of Chinese

Han, B., Hejun, L., Shan, X., Sun, Q., Fan, W., Liu, K., & Wang, H. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw044.574

Investigation for the involvement of microbial FliC and DING proteins in Alzheimer's Disease and Mild Cognitive Impairment and correlation with neurodegeneration and inflammation markers

Andreadou, E. G., Katsipis, G., Tsolaki, M., & Pantazaki, Α. A. (2023) · Brain Disorders · doi:10.1016/j.dscb.2023.100091 · Cited by 3 · see citing works

Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease

Do, K. V., Hjorth, E., Wang, Y., Jun, B., Kautzmann, M.-A. I., Ohshima, M., Eriksdotter, M., Schultzberg, M., & Bazan, N. G. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01216-5 · Cited by 65 · see citing works